Evidence map›Paper›PMID 36701093›Full record

ArticleApplied biochemistry and biotechnology2023

Multifunctional Iron Oxide Nanocarriers Synthesis for Drug Delivery, Diagnostic Imaging, and Biodistribution Study.

Farzana Raoof, Aisha Munawar, Munir Ahmad, Syed Faheem Askari Rizvi, Zahid Ali, Abu Bakar Shahid

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Iron-Based Nanoparticles as Delivery Tools.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Farzana RaoofDepartment of Chemistry, The University of Engineering and Technology, Lahore-54000, Punjab, Pakistan.
Aisha MunawarDepartment of Chemistry, The University of Engineering and Technology, Lahore-54000, Punjab, Pakistan. aisha.munawar@uet.edu.pk.
Munir AhmadDepartment of Oncology, Institute of Nuclear Medicine and Oncology (INMOL), Lahore-54000, Punjab, Pakistan.
Syed Faheem Askari RizviKey Laboratory of Preclinical Study for New Drugs of Gansu Province, and Institute of Physiology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, Gansu, People's Republic of China. faheem@lzu.edu.cn.ORCID http://orcid.org/0000-0002-8671-9168
Zahid AliDepartment of Chemistry, The University of Lahore, Lahore, 53700, Punjab, Pakistan.
Abu Bakar ShahidDepartment of Oncology, Institute of Nuclear Medicine and Oncology (INMOL), Lahore-54000, Punjab, Pakistan.
Institute of Radiotherapy and Nuclear Medicine · PKUniversity of Engineering and Technology Lahore · PKLanzhou University · CNUniversity of Lahore · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the current study is to design the radiolabeled and drug-loaded nanocarrier with high loading capacity and pH-dependent drug release characteristics that could effectively transport loaded compounds to various organs for efficient diagnostic imaging and chemotherapeutic drug delivery. The aqueous extract of green tea leaves was used to synthesize the small-sized iron oxide nanoparticles (IONPs). The nanoparticles were characterized with UV-visible spectroscopy, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and energy-dispersive X-ray analysis (EDX). Iron oxide nanoparticles with sizes smaller than 50 nm were successfully synthesized, making them suitable for in vivo studies. In drug loading trials, 94% of the drug was loaded onto the active surface of iron oxide nanoparticles from the solution. The in vitro drug release study revealed that an acidic environment (pH 4.5) effectively triggers the release of doxorubicin (DOX) from the nanoparticles as compared to a neutral environment (pH 7.4). The gamma-emitting radionuclide

Indexed as

DoxorubicinPlant ExtractsAnimalsDrug CarriersDrug LiberationFerric CompoundsMicroscopy, Electron, TransmissionRabbitsSpectroscopy, Fourier Transform InfraredTeaTissue DistributionDoxorubicinDrug CarriersFerric Compoundsferric oxidePlant ExtractsTeaDoxorubicinGreen tea extractIron oxideNanotherapeuticsRadiolabeling

Identifiers

PMID36701093
OpenAlexW4318054868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.